Displaying 680 results out of a total of 3930 publications.
Classical NF-B Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2
Londhe, P;Yu, PY;Ijiri, Y;Ladner, KJ;Fenger, JM;London, C;Houghton, PJ;Guttridge, DC;
Front Oncol, Front Oncol 8():104, 2018
View publication
Front Oncol, Front Oncol 8():104, 2018
PTEN deficiency confers colorectal cancer cell resistance to dual inhibitors of FLT3 and aurora kinase A
Liu, Y;Yang, EJ;Zhang, B;Miao, Z;Wu, C;Lyu, J;Tan, K;Poon, TCW;Shim, JS;
Cancer Lett., Cancer Lett. 436():28-37, 2018
View publication
Cancer Lett., Cancer Lett. 436():28-37, 2018
Lipid uptake is an androgen-enhanced lipid supply pathway associated with prostate cancer disease progression and bone metastasis
Tousignant, KD;Rockstroh, A;Taherian Fard, A;Lehman, ML;Wang, C;McPherson, SJ;Philp, LK;Bartonicek, N;Dinger, ME;Nelson, CC;Sadowski, MC;
Mol. Cancer Res., Mol. Cancer Res. ():, 2019
View publication
Mol. Cancer Res., Mol. Cancer Res. ():, 2019
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy
Lelliott, EJ;Cullinane, C;Martin, CA;Walker, R;Ramsbottom, KM;Souza-Fonseca-Guimaraes, F;Abuhammad, S;Michie, J;Kirby, L;Young, RJ;Slater, A;Lau, P;Meeth, K;Oliaro, J;Haynes, N;McArthur, GA;Sheppard, KE;
Sci Rep, Sci Rep 9(1):1225, 2019
View publication
Sci Rep, Sci Rep 9(1):1225, 2019
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Molina, JR;Sun, Y;Protopopova, M;Gera, S;Bandi, M;Bristow, C;McAfoos, T;Morlacchi, P;Ackroyd, J;Agip, AA;Al-Atrash, G;Asara, J;Bardenhagen, J;Carrillo, CC;Carroll, C;Chang, E;Ciurea, S;Cross, JB;Czako, B;Deem, A;Daver, N;de Groot, JF;Dong, JW;Feng, N;Gao, G;Gay, J;Do, MG;Greer, J;Giuliani, V;Han, J;Han, L;Henry, VK;Hirst, J;Huang, S;Jiang, Y;Kang, Z;Khor, T;Konoplev, S;Lin, YH;Liu, G;Lodi, A;Lofton, T;Ma, H;Mahendra, M;Matre, P;Mullinax, R;Peoples, M;Petrocchi, A;Rodriguez-Canale, J;Serreli, R;Shi, T;Smith, M;Tabe, Y;Theroff, J;Tiziani, S;Xu, Q;Zhang, Q;Muller, F;DePinho, RA;Toniatti, C;Draetta, GF;Heffernan, TP;Konopleva, M;Jones, P;Di Francesco, ME;Marszalek, JR;
Nat. Med., Nat. Med. ():, 2018
View publication
Nat. Med., Nat. Med. ():, 2018
Characterization of canine adipose-derived mesenchymal stromal/stem cells in serum-free medium
Liu, Z;Screven, R;Boxer, L;Myers, M;Devireddy, L;
Tissue Eng Part C Methods, Tissue Eng Part C Methods ():, 2018
View publication
Tissue Eng Part C Methods, Tissue Eng Part C Methods ():, 2018
Somatic PRDM2 c. 4467delA mutations in colorectal cancers control histone methylation and tumor growth
Pandzic, T;Rendo, V;Lim, J;Larsson, C;Larsson, J;Stoimenov, I;Kundu, S;Ali, MA;Hellstrm, M;He, L;Lindroth, AM;Sjblom, T;
Oncotarget, Oncotarget ():, 2017
View publication
Oncotarget, Oncotarget ():, 2017
A functional genomics screen reveals a strong synergistic effect between docetaxel and the mitotic gene DLGAP5 that is mediated by the androgen receptor
Hewit, K;Sandilands, E;Martinez, RS;James, D;Leung, HY;Bryant, DM;Shanks, E;Markert, EK;
Cell Death Dis, Cell Death Dis 9(11):1069, 2018
View publication
Cell Death Dis, Cell Death Dis 9(11):1069, 2018
GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy
Im, JH;Kang, KW;Kim, SY;Kim, YG;An, YJ;Park, S;Jeong, BH;Choi, SY;Lee, JS;Kang, KW;
J. Exp. Clin. Cancer Res., J. Exp. Clin. Cancer Res. 37(1):295, 2018
View publication
J. Exp. Clin. Cancer Res., J. Exp. Clin. Cancer Res. 37(1):295, 2018
The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo
Xu, N;Hua, Z;Ba, G;Zhang, S;Liu, Z;Thiele, CJ;Li, Z;
J. Exp. Clin. Cancer Res., J. Exp. Clin. Cancer Res. 38(1):118, 2019
View publication
J. Exp. Clin. Cancer Res., J. Exp. Clin. Cancer Res. 38(1):118, 2019